Up a level |
Number of items: 1.
Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison et al (show 9 more authors)
(2019)
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.
Journal of Clinical Oncology, 37 (30).
pp. 2722-2730.